Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 3/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL262605 | 0.96 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL25658208 | 0.93 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL23119087 | 0.91 | L3MBTL1 (0.50) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL26481080 | 0.90 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL25671891 | 0.90 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL20633654 | 0.90 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL26481064 | 0.90 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL23118994 | 0.90 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL262528 | 0.90 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL261838 | 0.90 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263055-A1 | ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230263055-A1 | ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-11665960-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-30 | — | — | US | disclosed |
| US-11665960-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263055-A1 | ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE | NR2E3, CRY1, RPS19 | L3MBTL1 618/4885KDM4E 3439/4885ATM 1094/4885 |
| US-11665960-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | NR2E3, CRY1, RPS19 | L3MBTL1 618/4885KDM4E 3439/4885ATM 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.